Xtant Medical Holdings Inc
For the period ended Dec 31, 2024. Filed Mar 6, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 6, 2025
XTNT$0.28-3.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
(In thousands, except number of shares and per share amounts)
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Revenue | ||
| Product revenue | $115,765 | $91,303 |
| License revenue | 1,502 | — |
| Total Revenue | 117,267 | 91,303 |
| Cost of Sales | 49,051 | 35,836 |
| Gross Profit | 68,216 | 55,467 |
| Operating Expenses | ||
| General and administrative | 28,691 | 25,850 |
| Sales and marketing | 49,214 | 38,439 |
| Research and development | 2,385 | 1,336 |
| Total Operating Expenses | 80,290 | 65,625 |
| Loss from Operations | (12,074) | (10,158) |
| Other (Expense) Income | ||
| Interest expense | (4,160) | (2,938) |
| Interest income | — | 149 |
| Unrealized foreign currency translation gain | 5 | 265 |
| Bargain purchase gain | — | 11,694 |
| Other expense | (33) | (49) |
| Total Other (Expense) Income | (4,188) | 9,121 |
| Net Loss from Operations Before Provision for Income Taxes | (16,262) | (1,037) |
| (Provision) Benefit for Income Taxes Current and Deferred | (187) | 1,697 |
| Net (Loss) Income | $(16,449) | $660 |
| Net (Loss) Income Per Share: | ||
| Basic | $(0.12) | $0.01 |
| Dilutive | $(0.12) | $0.01 |
| Shares used in the computation: | ||
| Basic | 133,665,075 | 119,093,687 |
| Dilutive | 133,665,075 | 126,793,318 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.